全球基因组资料管理区块链市场规模（按服务类型、应用、区域范围划分）预测至 2025 年

区块链在基因组资料管理中的市场规模与预测

2020 年，基因组资料管理中的区块链市场规模价值 3,998 万美元，预计到 2028 年将达到 20.6752 亿美元，2021 年至 2028 年的复合年增长率为 63.76%。

私人公司和创投的投资不断增加，推动了基因组数据管理区块链市场的成长。此外，基因组学的发展、数位工具的日益采用以及患者医疗服务的数位化等因素也在推动市场成长。全球基因组数据管理区块链市场报告对市场进行了全面评估。它对关键细分市场、趋势、市场推动因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

基因组资料管理中区块链的全球市场定义

区块链是一种数位化的、以区块形式储存的交易和资料的公共分类帐。区块链提供了一个可以在互连的资料库系统之间共享的去中心化资料网路。区块链技术采用带有时间戳记的、不可变的资料区块系统，使得世界上任何地方任何拥有连网系统的人只要获得适当的授权就可以存取它。这项技术让用户可以控制自己的资料分发，从而保护自己的隐私。非对称加密（公钥加密）允许用户加密资料以增加安全性。

但如果你出售或捐赠你的数据，接收者会得到一个私钥来解密数据，确保未经授权的第三方无法存取它。区块链技术将储存、管理和交换基因组数据。区块链采用分散的资讯管理模型，这对银行和金融业有利。生物製药和基因组研究公司正在使用区块链来处理基因组数据提供者与其客户之间的基因组数据交易和支付。它也有助于决策。区块链平台将实现数据提供者（用户）与购买者（药厂、研究机构）之间的直接互动。

此外，加密金钥还可以在资料交换过程中保持使用者的匿名性。这些买家可以使用数据集来研究特定人群的基因模式，并根据分析的基因图谱开发药物和其他治疗方法。透过使用加密区块，区块链降低了资料修改或篡改的风险，从而为罕见疾病的新诊断和治疗方法的研究和开发创建了可靠的资料库。该技术最着名的应用是比特币和以太坊。该技术创造了一个透明、可追溯、但不可腐蚀的链模型。分散的时间戳系统允许区块链在没有中央权威的情况下运行，从而防止单点故障。交易在该网路的所有参与者之间直接且安全地进行。

基因组资料管理区块链的全球市场概况

私人公司和创投的投资不断增加，推动了基因组数据管理区块链市场的成长。该领域的其他近期活动，例如製药公司和相关政府机构建立战略合作伙伴关係，以及风险资本家/其他利益相关者的投资，都是使用区块链平台来储存和管理遗传资讯。正在获得医疗保健行业的支持。这些举措可能会在未来几年推动整个市场的成长。此外，基因组学的不断发展、数位工具的日益采用以及患者医疗服务的数位化等因素也在推动市场成长。

当今的医疗保健资料管理系统涉及资料收集、资料共享、分析成本、资料所有权、隐私和安全。该领域最重要和最关键的方面是数据采集。资料云架构旨在透过安全的方式储存资料来解决单点故障问题。区块链有可能降低基因组和医疗保健分析的价格。与现有系统的工作方式相反，如果资料所有者可以直接联繫资料购买者，而无需透过中介，那么这可以降低分析成本和资料所有者的收入。这些声明也适用于电子医疗应用程式。

使用区块链系统，交易可以比透过传统流程更快、更有效率地完成。然而，对于大量的基因组和临床数据，很少有可靠、安全的数据管理资源能够提供安全的储存、无缝的资讯交换和值得信赖的交易平台。然而，对资料安全和隐私的担忧正在限制基因组资料管理的区块链市场的发展。您的个人资料的安全和隐私非常重要。儘管比特币提供了伪匿名性，但没有系统可以提供完全匿名性。

基因组学和医疗保健领域的另一个敏感问题是人们不愿意直接提供他们的原始数据。例如，透过检查一个人的整个基因组数据，我们可以识别该人并获得有关其祖先的资讯。区块链系统中的交易以哈希值存储，而不是原始资料。此外，个人隻共享元数据，即有关数据的一般资讯。此外，医疗器材行业的创新产品和发展以及行动智慧型手机的不断增长的使用为该市场带来了巨大的机会。

目录

第 1 章。

市场概况
• 研究范围
• 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第 4 章 基因组资料管理区块链的全球市场展望

• 概述
• 市场动态
  • 驱动程式
  • 阻碍因素
  • 机会
• 波特五力模型
• 价值链分析

5. 全球基因组资料管理区块链市场（按服务类型）

• 概述
• B2B 商业模式
• B2C 商业模式
• C2B 商业模式

• 概述
• 製药公司
• 研究机构
• 资料拥有者
• 其他

7. 全球基因组资料管理区块链市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
  亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 拉丁美洲
  • 中东和非洲

第 8 章。

• 概述
• 各公司的市场排名
• 主要发展策略

第九章 公司简介

• DNATIX LTD.
• NEBULA GENOMICS
• GENOMES.IO
• ENCRYPGEN INCORPORATED
• SHIVOM VENTURES LTD
• GENEBLOCKCHAIN, LLC
• 23ANDME, INC.
• 10X GENOMICS
• ZENOME
• IIF Management Co. LLC.

第 10 章附录

• 相关研究

Blockchain In Genomic Data Management Market Size And Forecast

Blockchain In Genomic Data Management Market size was valued at USD 39.98 Million in 2020 and is projected to reachUSD 2067.52 Million by 2028, growing at aCAGR of 63.76% from 2021 to 2028.

Rising investment by private players and venture capitalists helps to boost the Blockchain In Genomic Data Management Market growth. Moreover, factors such as rising developments in genomics, rising adoption of digital tools, and digitization of healthcare services by patients fuel the market growth. The Global Blockchain In Genomic Data Management Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Blockchain In Genomic Data Management Market Definition

Blockchain is a digitalized public ledger of transactions and data stored as blocks. Blockchain provides a decentralized network of distributable data that can be shared between interconnected database systems. Blockchain technology utilizes a timestamped immutable system of blocks containing data, making them accessible to anyone with a connected system, anywhere in the world, as long as they receive proper authorization. This technology allows users control over the distribution of their data, thereby protecting their privacy. Using asymmetric cryptography (Public Key Cryptography), users can encrypt their data for added security.

When selling or donating data, however, the receiver is granted a private key to decrypt the data, ensuring that no non-permitted third parties have access. Blockchain technology stores, manage and exchange genomic data. The blockchain utilizes a decentralized information management model that is beneficial for banking and financial areas. Blockchain is used in biopharmaceutical and genomic research companies to process the transactions of genomic data and payments between genomic data providers and their customers. It also provides help in decision-making. The blockchain platform allows data providers (users) and buyers to interact directly (pharma companies, research institutes).

Additionally, the cryptographic keys also maintain the anonymity of users during data exchange. These buyers may then use the sets of data to research genetic patterns in a specific population, allowing for the development of drugs and other therapies based on the genetic profiles analyzed. Blockchain reduces the risk of data modification and tampering by using cryptographic blocks, resulting in an authentic database for research and the creation of new diagnostics and treatment options for rare disorders. The best-known applications of this technology are Bitcoin and Ethereum. It creates a chain model that can be transparently tracked but cannot be broken. With a distributed timestamp system, blockchain permits operation without a central authority, preventing single-point-of-failure. Transactions may be carried out directly and safely among all participants in this network.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Blockchain In Genomic Data Management Market Overview

Rising investment by private players and venture capitalists helps to boost the Blockchain In Genomic Data Management Market growth. Recent activities in this domain, such as the formation of strategic partnerships (involving pharmaceutical players and relevant government bodies) and venture capital/other stakeholder investments, indicate that the concept of using blockchain platforms for the storage and management of genetic information is gaining traction in the healthcare industry. such efforts will help the market's overall growth in the coming years. Additionally, factors such as increasing developments in genomics, rising adoption of digital tools, and digitization of healthcare services by patients drive the market growth.

Today's healthcare data management systems are concerned with data collection, data sharing, analysis expenses, data ownership, privacy, and security. The most important and significant aspect of this field is obtaining data. Data Cloud Architecture was designed to address the single point of failure problem by storing data in a secure and safe way. The blockchain has the potential to reduce the price of genomics and healthcare analysis. In contrast to how the existing systems work, if data owners can contact data buyers directly without going through an intermediary, both the analysis costs and the data owners' income can be reduced. These statements apply to electronic healthcare apps as well.

Transactions are completed faster and more effectively using blockchain systems than with conventional processes. However, for large volumes of genomic and clinical data, there are few reliable and secure data management resources that would provide safe storage, seamless information exchange, and a reliable transaction platform. However, data security and privacy concerns are restraining factors for the Blockchain In Genomic Data Management Market. The security and privacy of personal data are very important. Bitcoin provides pseudo-anonymity, despite the fact that no system can give complete anonymity.

Another sensitive issue in genomics and healthcare is that people do not want to give their original data directly. For instance, by examining an individual's entire genome data, the person may be identified, and information about his or her ancestors can be obtained. Instead of the original data, transactions in blockchain systems are saved with their hash values. Individuals also only share metadata, which is information about the data in general. Furthermore, innovative products and development in the medical device industry and the increase in the use of mobile smartphones are the major opportunities in front of this market.

Global Blockchain In Genomic Data Management Market Segmentation Analysis

The Global Blockchain In Genomic Data Management Market is Segmented on the basis of Service Type, Application, And Geography.

Blockchain In Genomic Data Management Market, By Service Type

• B2B Business Model
• B2C Business Model
• C2B Business Model

Based on Service Type, the market is segmented into B2B Business Model, B2C Business Model, and C2B Business Model. A business model is a company's plan or strategy for selling a product or service and profiting from it. Each organization will develop its own methods used to conduct business. There is, however, a central model that includes the owners or shareholders, the organization, consumers, and employees. Blockchain can act as a virtual bank for B2B companies, moving money, accepting deposits, finalizing transactions, and more. This is in contrast to online banking, which is subject to regulation, monitoring, business hours, and other restrictions.

Blockchain In Genomic Data Management Market, By Application

• Pharmaceutical Companies
• Research Institutes
• Data Owners
• Others

Based on Application, the market is segmented into Pharmaceutical Companies, Research Institutes, Data Owners, and Others. The majority of companies are involved in offering services primarily to pharmaceutical companies and research institutes. In addition, the companies also offer genomic data management through blockchain platforms to other key stakeholders such as data owners, software developers, and insurers.

Blockchain In Genomic Data Management Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global Blockchain In Genomic Data Management Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. More than 35% of the total number of players are headquartered in North America, primarily in the United States. EncrypGen, GnoMine, LunaDNA, and Nebula Genomics are some of the players based in this region.

Key Players

• The "Global Blockchain In Genomic Data Management Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
• DNATIX LTD, NEBULA GENOMICS, GENOMES.IO, ENCRYPGEN INCORPORATED, SHIVOM VENTURES LTD., GENEBLOCKCHAIN, LLC., 23ANDME, INC., 10X GENOMICS, ZENOME, IIF Management CO. LLC.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET, BY SERVICE TYPE

• 5.1 Overview
• 5.2 B2B Business Model
• 5.3 B2C Business Model
• 5.4 C2B Business Model

6 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Pharmaceutical Companies
• 6.3 Research Institutes
• 6.4 Data Owners
• 6.5 Others

7 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL BLOCKCHAIN IN GENOMIC DATA MANAGEMENT MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 DNATIX LTD.
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 NEBULA GENOMICS
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 GENOMES.IO
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 ENCRYPGEN INCORPORATED
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 SHIVOM VENTURES LTD
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 GENEBLOCKCHAIN, LLC
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 23ANDME, INC.
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 10X GENOMICS
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 ZENOME
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments
• 9.10 IIF Management Co. LLC.
  • 9.10.1 Overview
  • 9.10.2 Financial Performance
  • 9.10.3 Product Outlook
  • 9.10.4 Key Developments

10 Appendix

• 10.1 Related Research